aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a hybrid distribution strategy via distribution agents and partnerships with global orthopaedic and medical technology companies.
In North America, aap’s 3Q15 sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.
Sources: aap Implantate AG; ORTHOWORLD Inc.
aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a...
aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a hybrid distribution strategy via distribution agents and partnerships with global orthopaedic and medical technology companies.
In North America, aap’s 3Q15 sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.
Sources: aap Implantate AG; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.